Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 4 Planned sale President and COO sold 69,061 shares at an average $14.60 ($1,008,622)
  4. 4 Planned sale President and COO sold 57,180 shares at an average $14.45 ($826,251)
  5. 4 Planned sale President and COO sold 57,180 shares at an average $13.26 ($758,108)
  6. 4 Planned sale Chief People Officer sold 22,564 shares at $15.07 ($340,039)
  7. 4 Planned sale Chief Scientific Officer sold 10,000 shares at $14.85 ($148,500)
  8. 4 Planned sale CEO and Chairman sold 120,595 shares at an average $14.65 ($1,766,839)
  9. 4 Planned sale President and COO sold 69,061 shares at an average $14.34 ($990,503)
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 4 Planned sale President and COO sold 38,120 shares at an average $14.53 ($553,693)
  15. 4 Planned sale President and COO sold 57,180 shares at an average $13.14 ($751,303)
  16. 4 Planned sale President and COO sold 57,180 shares at an average $14.03 ($802,235)
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 4 Planned sale President and COO sold 57,180 shares at an average $13.46 ($769,643)
  19. 4 Planned sale President and COO sold 57,180 shares at an average $13.33 ($762,209)
  20. 144 Insider Sale of Securities

Page 5 of 42 · 836 filings